Cost of the screening programme and direct and indirect costs associated with Chlamydia trachomatis infections and sequelae in women (price level 1996, in US$)
| Variable | Direct (medical) cost | Indirect cost |
|---|---|---|
| *For every woman invited to participate. | ||
| †For every participant. | ||
| ‡Costs presented in the table are for women aged 15–25 years and are not discounted. In the model, all future costs were discounted at a rate of 3% per year. | ||
| Coordination of the program (2 fulltime social workers, cost per person) | 48 309 per year | — |
| Recruitment cost* (container, envelope, postage) | 0.48 | — |
| Laboratory test† (postage, materials, and labour) | 17.29 | — |
| Treatment (1000 mg azithromycin) | 9.52 | — |
| GP consultation | 15.51 | — |
| Symptomatic PID | ||
| Inpatient treatment | 3 908 | 276 |
| Outpatient treatment | 67 | 132 |
| Infertility‡ | ||
| Inpatient evaluation | 2 315 | 212 |
| Outpatient evaluation | 805 | 286 |
| In vitro fertilisation‡ | 1 423 | 188 |
| Ectopic pregnancy‡ | 2 909 | 847 |
| Chronic pelvic pain‡ | ||
| Inpatient treatment | 3 310 | 456 |
| Outpatient treatment | 587 | 217 |
| Neonatal conjunctivitis | 39 | — |
| Neonatal pneumonia | ||
| Inpatient treatment | 16 150 | — |
| Outpatient treatment | 94 | 9 |